Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Public Health Nutrition|June 17, 2022
Dietary changes based on food purchase patterns following a type 2 diabetes diagnosisAnna Kristina Edenbrandt, Bettina Ewers, Heidi Storgaard, et al.Ugeskrift for Laeger|October 3, 2018
[Cholesterol-lowering treatment with PCSK9-inhibitors]Michael E Røder, Per Hildebrandt, Heidi Storgaard, et al.Clinical Physiology and Functional Imaging|May 30, 2018
Cardiometabolic effects of antidiabetic drugs in non-alcoholic fatty liver diseaseIben Rix, Julie Steen Pedersen, Heidi Storgaard, et al.The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Relationships of plasma adiponectin level and adiponectin receptors 1 and 2 gene expression to insulin sensitivity and glucose and fat metabolism in monozygotic and dizygotic twinsHeidi Storgaard, Pernille Poulsen, Charlotte Ling, et al.The Journal of Clinical Endocrinology and Metabolism|November 18, 2005
Genetic and nongenetic determinants of skeletal muscle glucose transporter 4 messenger ribonucleic acid levels and insulin action in twinsHeidi Storgaard, Pernille Poulsen, Charlotte Ling, et al.Ugeskrift for Laeger|September 22, 2016
[Sodium-glucose cotransporter 2 (SGLT-2) inhibitors for patients with Type 2 diabetes]Michael Einar Røder, Heidi Storgaard, Jørgen Rungby, et al.Diabetes Care|April 30, 2002
Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetesKjeld Hermansen, Michele Colombo, Heidi Storgaard, et al.Metabolism: Clinical and Experimental|July 19, 2003
Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetesHeidi Storgaard, Christine B Jensen, Allan A Vaag, et al.Basic & Clinical Pharmacology & Toxicology|August 21, 2015
Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor TreatmentHeidi Storgaard, Jonatan I Bagger, Filip K Knop, et al.BMJ Open|September 19, 2014
The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trialsHeidi Storgaard, Lise Lotte Gluud, Mikkel Christensen, et al.Pageof 5